Skip to main content
. 2022 Mar 16;13:813732. doi: 10.3389/fimmu.2022.813732

Table 1.

Summary of clinical information.

Number %
Sex
 Male 92 76.0%
 Female 29 24.0%
Age (years)
 Median 57 (27–79)
Cancer type
 Oral squamous cell carcinoma 91 75.2%
 Oropharyngeal carcinoma 23 19.0%
  P16 positive 5 4.1%
  P16 negative 18 14.9%
 Other cancer type 7 5.8%
PD-L1
 CPS < 1 30 25.0%
 CPS ≥ 1 84 69.4%
 Unknown 7 6.0%
Number of prior lines
of therapy*
 0 70 NA
 ≥1 60 NA

*9 patients were treated with both PD-1 antibody and EGFR antibody at different lines. NA, not applicable.